Filter News
Area of Research
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (1)
- (-) Clean Water (1)
- (-) Cybersecurity (1)
- (-) Machine Learning (1)
- (-) Quantum Science (1)
- (-) Summit (1)
- Artificial Intelligence (1)
- Biology (2)
- Computer Science (3)
- Decarbonization (1)
- Energy Storage (4)
- Environment (4)
- Frontier (1)
- Materials (3)
- Materials Science (3)
- National Security (1)
- Neutron Science (20)
- Nuclear Energy (1)
- Physics (3)
- Security (1)
- Space Exploration (1)
- Transportation (1)
Media Contacts
Scientists at ORNL used neutron scattering to determine whether a specific material’s atomic structure could host a novel state of matter called a spiral spin liquid.
ORNL researchers used the nation’s fastest supercomputer to map the molecular vibrations of an important but little-studied uranium compound produced during the nuclear fuel cycle for results that could lead to a cleaner, safer world.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
Illustration of the optimized zeolite catalyst, or NbAlS-1, which enables a highly efficient chemical reaction to create butene, a renewable source of energy, without expending high amounts of energy for the conversion. Credit: Jill Hemman, Oak Ridge National Laboratory/U.S. Dept. of Energy
ORNL computer scientist Catherine Schuman returned to her alma mater, Harriman High School, to lead Hour of Code activities and talk to students about her job as a researcher.
Researchers at the Department of Energy’s Oak Ridge National Laboratory, Pacific Northwest National Laboratory and Washington State University teamed up to investigate the complex dynamics of low-water liquids that challenge nuclear waste processing at federal cleanup sites.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.